PRN: Global Cartilage Repair Market 2017-2021 with Acelity, DePuy Synthes, Stryker & Smith & Nephew Dominating

31/ago/2017 17:30:13 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Cartilage Repair Market 2017-2021 with Acelity, DePuy Synthes, Stryker & Smith & Nephew Dominating

 
[31-August-2017]
 

DUBLIN, August 31, 2017 /PRNewswire/ --

The "Global Cartilage Repair Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global cartilage repair market to grow at a CAGR of 11.59 % during the period 2017-2021.

The treatment of articular cartilage has evolved tremendously in the past decade. Reparative and restorative methods have been developed to address the significant source of morbidity in the young and active patients. Articular cartilage injury can be focal, which is localized or systemic. Procedures are being developed not only to alleviate the symptoms associated with articular cartilage defects but also to limit the progression of cartilage damages into degenerative diseases.

According to the report, one of the major drivers for this market is Rising incidence of accidental injuries. Globally, the road traffic injuries are increasing, with post complicated symptoms such as weakening of tendons, cartilage tear, and orthopedic issues.

The latest trend gaining momentum in the market is Gene therapy and stem cell therapy. Gene therapy is one of the promising fields in the cartilage repair. Many clinical studies have been performed for cartilage repair. The researchers are trying to develop gene therapy for cartilage repair and currently been investigated for clinical application.

Further, the report states that one of the major factors hindering the growth of this market is Product side effects. Surgeons use cartilage repair products such as tissue scaffold to improve the recovery. These products once grafted in the body may cause serious complications, resulting in their increased scrutiny for safety and efficacy. In many autologous chondrocyte implantation, there were common complications such as graft rejection, symptomatic hypertrophy, disturbed fusion and delamination.

Key vendors

  • Acelity
  • DePuy Synthes
  • Stryker
  • Smith & Nephew

Other prominent vendors

  • AlloSource
  • Bio-Tissue
  • CellGenix
  • Collagen Solutions
  • Geistlich Pharma
  • Orteq
  • RTI Surgical
  • TORNIER
  • Vericel
  • XTANT MEDICAL

Key Topics Covered:

  1. Executive Summary
  2. Scope Of The Report
  3. Research Methodology
  4. Introduction
  5. Market Landscape
  6. Market Segmentation By Product
  7. Market Segmentation By End-User
  8. Geographical Segmentation
  9. Drivers And Challenges
  10. Market Trends
  11. Vendor Landscape
  12. Key Vendor Analysis
  13. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/sng3nx/global_cartilage

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl